benzocaine 0.18 MG/MG Oral Gel [Topicale]
- RxCUI
- 1049213
- RxNorm name
- benzocaine 0.18 MG/MG Oral Gel [Topicale]
- Display name
- TOPICALE (Oral Gel)
- Full name
- benzocaine 0.18 MG/MG Oral Gel [Topicale]
- Term type
- SBD
- Status
- Active
- Strength
- 18%
- Dose form
- Gel
- Route
- Oral Gel
- Updated
- 2026-06-05 07:07:47
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012011
- Active start
- 012011
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| benzocaine | 0.18 MG / 1 MG | benzocaine | benzocaine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Gel | 346169 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzocaine | 1399 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Topicale 18 % Oral Gel | 1 | NAMES |
| RxNorm Name | benzocaine 0.18 MG/MG Oral Gel [Topicale] | 1 | NAMES |
| RxNorm Synonym | 2 linked values | 2 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1049213 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 10733-166-35 | 10733-166 | Topicale Benzocaine | Medical Products Laboratories, Inc. | M022 |
| 10733-167-43 | 10733-167 | Topicale Benzocaine | Medical Products Laboratories, Inc. | M022 |
| 10733-169-43 | 10733-169 | Topicale Benzocaine | Medical Products Laboratories, Inc. | M022 |
| 10733-170-43 | 10733-170 | Topicale Benzocaine | Medical Products Laboratories, Inc. | M022 |
| 10733-171-43 | 10733-171 | Topicale Benzocaine | Medical Products Laboratories, Inc. | M022 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topicale | BENZOCAINE | Medical Products Laboratories, Inc. | 826eaef8-4457-3dc2-e053-2991aa0a528b | 2024-12-11 | Warnings | 10733-166-35 10733-166 10733016635 1049213 |
| Topicale | BENZOCAINE | Medical Products Laboratories, Inc. | 8281700c-10f9-841c-e053-2991aa0a918f | 2024-12-11 | Warnings | 10733-169-43 10733-170-43 10733-171-43 10733-167-43 10733-171 10733-170 10733-167 10733-169 10733017043 10733016743 10733016943 10733017143 1049213 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 826eaef8-4457-3dc2-e053-2991aa0a528b | Topicale 18 % Oral Gel [PSN] · benzocaine 0.18 MG/MG Oral Gel [Topicale] [SBD] · Topicale 0.18 MG/MG Oral Gel [SY] · Topicale 18 % Oral Gel [SY] | 4 | 4 | Topicale Gel Jar | 20241211 |
| 8281700c-10f9-841c-e053-2991aa0a918f | Topicale 18 % Oral Gel [PSN] · benzocaine 0.18 MG/MG Oral Gel [Topicale] [SBD] · Topicale 0.18 MG/MG Oral Gel [SY] · Topicale 18 % Oral Gel [SY] | 4 | 3 | Topicale Gel Pump | 20241211 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 826eaef8-4457-3dc2-e053-2991aa0a528b | Topicale Gel Jar | Medical Products Laboratories, Inc. | 20241211 |
| 8281700c-10f9-841c-e053-2991aa0a918f | Topicale Gel Pump | Medical Products Laboratories, Inc. | 20241211 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | benzocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | benzocaine | |
| ATC | N01BA | Esters of aminobenzoic acid | ATC1-4 | benzocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | benzocaine | |
| FDASPL | N0000185508 | Standardized Chemical Allergen | EPC | has_epc | benzocaine |
| FDASPL | N0000184306 | Cell-mediated Immunity | PE | has_pe | benzocaine |
| FDASPL | N0000175629 | Increased Histamine Release | PE | has_pe | benzocaine |
| MEDRT | D001566 | Benzocaine | CHEM | has_ingredient | benzocaine |
| MEDRT | D001424 | Bacterial Infections | DISEASE | ci_with | benzocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | benzocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzocaine |
| MEDRT | D004433 | Earache | DISEASE | may_treat | benzocaine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | benzocaine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | benzocaine |
| MEDRT | D006561 | Herpes Simplex | DISEASE | may_treat | benzocaine |
| MEDRT | D019226 | Oral Ulcer | DISEASE | may_treat | benzocaine |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | benzocaine |
| MEDRT | D010033 | Otitis Media | DISEASE | may_treat | benzocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | benzocaine |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | benzocaine |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | benzocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | benzocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | benzocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.18 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | Topicale 18 % Oral Gel |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |